Abuse-Deterrence Among New GDUFA Regulatory Science Priorities
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA says it will need tools to evaluate technologies designed to deter nasal abuse in generics.
You may also be interested in...
US FDA's Generic Research Projects Appear To Be Opening Way For ANDAs
Pre-ANDA meeting requests were high in some product categories where FDA conducted research projects, suggesting agency may influence sponsors' development priorities.
US FDA's Generic Research Projects Appear To Be Opening Way For ANDAs
Pre-ANDA meeting requests were high in some product categories where FDA conducted research projects, suggesting agency may influence sponsors' development priorities.
Drug Shortage Prevention Could Be Funded Through GDUFA
GPhA recommends FDA deploy user fee research money to look at shortage risk assessment and mitigation strategies, while the trade group continues to look for a product to fit its own shortage prediction model.